摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-4,5-二甲氧基苯甲酸甲酯 | 17667-32-2

中文名称
2-溴-4,5-二甲氧基苯甲酸甲酯
中文别名
——
英文名称
methyl 6-bromo-3,4-dimethoxybenzoate
英文别名
methyl 2-bromo-4,5-dimethoxybenzoate;2-bromo-4,5-dimethoxybenzoic acid methyl ester
2-溴-4,5-二甲氧基苯甲酸甲酯化学式
CAS
17667-32-2
化学式
C10H11BrO4
mdl
MFCD00017182
分子量
275.099
InChiKey
BCUHOZBMHZWCGL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    86-88 °C
  • 沸点:
    325.3±37.0 °C(Predicted)
  • 密度:
    1.436±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2918990090

SDS

SDS:b49bf2468c527600b517bc3885ea868a
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Methyl 2-bromo-4,5-dimethoxybenzoate
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 2-bromo-4,5-dimethoxybenzoate
CAS number: 17667-32-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H11BrO4
Molecular weight: 275.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-溴-4,5-二甲氧基苯甲酸甲酯 在 palladium diacetate 盐酸硫酸 、 ammonium acetate 、 sodium methylatesodium acetate三乙胺三苯基膦 作用下, 以 四氢呋喃1,4-二氧六环甲醇乙醇溶剂黄146甲苯乙腈 为溶剂, 反应 50.0h, 生成 2-hydroxy-6,7-dimethoxy-3-phenyl-[1,4]naphthoquinone
    参考文献:
    名称:
    钯催化邻乙酰基苯甲酸的合成:2-羟基-3-苯基-1,4-萘醌和吲哚[2,3 - b ]萘-6,11-二酮的新有效途径
    摘要:
    我们在这里描述了一种新的,高效的,一般的合成方法,该方法通过Heck钯催化的正丁基乙烯基醚与邻溴代苯甲酸酯的芳基化反应来合成邻乙酰基苯甲酸,并将这些化合物用作合成3-苄叉基异色满1的原料,4-二酮,其容易重排为2-羟基-3-苯基-1,4-萘醌。还描述了该策略在吲哚[2,3 - b ]萘-6,11-二酮合成中的应用。
    DOI:
    10.1016/s0040-4039(02)00990-5
  • 作为产物:
    描述:
    3,4-二甲氧基苯甲酸甲酯 作用下, 以 溶剂黄146 为溶剂, 反应 2.25h, 以64.2%的产率得到2-溴-4,5-二甲氧基苯甲酸甲酯
    参考文献:
    名称:
    MRTX0902 的设计和发现,一种 SOS1:KRAS 蛋白质-蛋白质相互作用的强效、选择性、脑渗透性和口服生物可利用抑制剂
    摘要:
    SOS1 是主要的鸟嘌呤核苷酸交换因子之一,可调节 KRAS 循环通过其“开”和“关”状态的能力。破坏 SOS1:KRAS G12C蛋白质-蛋白质相互作用 (PPI) 可以增加负载 GDP 的 KRAS G12C 的比例,为将 SOS1:KRAS 复合物的抑制剂与靶向 GDP 负载的 KRAS G12C的抑制剂(如 MRTX849)组合提供强有力的机制原理。在本报告中,我们详细介绍了 MRTX0902 的设计和发现——一种有效、选择性、脑渗透性和口服生物可利用的 SOS1 结合剂,可破坏 SOS1:KRAS G12C生产者价格指数。MRTX0902 与 MRTX849 联合口服给药相对于任一单一药物的抗肿瘤活性显着增加,包括 MIA PaCa-2 肿瘤小鼠异种移植模型中一部分动物的肿瘤消退。
    DOI:
    10.1021/acs.jmedchem.2c00741
点击查看最新优质反应信息

文献信息

  • A Pd-catalyzed, boron ester-mediated, reductive cross-coupling of two aryl halides to synthesize tricyclic biaryls
    作者:Zhilong Chen、Xiaodong Wang
    DOI:10.1039/c7ob01237c
    日期:——
    Tricyclic biaryls are important scaffold structures in many natural products and lead compounds in drug discovery. The formation of a biaryl unit is often the key step for the synthesis of tricyclic biaryls. Despite significant progress toward the synthesis of biaryl compounds in recent years, the direct cross-coupling of two different aryl halides is still challenging and robust methods are lacking
    三环联芳基在许多天然产物中是重要的支架结构,在药物发现中是先导化合物。联芳基单元的形成通常是合成三环联芳基的关键步骤。尽管近年来在合成联芳基化合物方面取得了重大进展,但是两种不同的芳基卤化物的直接交叉偶联仍然具有挑战性,并且缺乏可靠的方法。在本文中,我们报道了在催化剂和硼酸酯存在下两种不同的芳基卤化物的直接交叉偶联,这为合成三环联芳基提供了一种新的有用的互补方法。
  • [EN] SOS1 INHIBITORS<br/>[FR] INHIBITEURS DE SOS1
    申请人:MIRATI THERAPEUTICS INC
    公开号:WO2021127429A1
    公开(公告)日:2021-06-24
    The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
    本发明涉及抑制七无子同源物1(SOS1)活性的化合物。具体而言,本发明涉及化合物、药物组合物和使用方法,例如使用本发明的化合物和药物组合物治疗癌症的方法。
  • Construction of a Protoberberine Alkaloid Skeleton via the Palladium-Catalyzed α-Arylation–Amide Formation Cascade
    作者:Shaofeng Li、Hanyu Nie、Mengyan Duan、Wenfei Wang、Congjun Zhu、Chuanjun Song
    DOI:10.1021/acs.orglett.1c03871
    日期:2021.12.17
    strategy of one-pot synthesis of protoberberine alkaloid derivatives via palladium-catalyzed cascade α-arylation and cyclization, which can afford the target molecules in moderate to excellent isolated yields using commercially available raw materials under solvent-free conditions. This protocol provides an efficient and convenient path to multisubstituted protoberberine derivatives. In addition, it can
    在这项工作中,我们报告了通过催化的级联α-芳基化和环化一锅法合成原小檗碱生物的策略,该策略可以在无溶剂条件下使用市售原料以中等至优异的分离产率提供目标分子. 该协议为多取代的原小檗碱生物提供了一条高效便捷的途径。此外,它可以直接负担天然生物碱
  • Carbonylative Suzuki–Miyaura couplings of sterically hindered aryl halides: synthesis of 2-aroylbenzoate derivatives
    作者:Aya Ismael、Troels Skrydstrup、Annette Bayer
    DOI:10.1039/d0ob00044b
    日期:——
    diversely substituted 2-aroylbenzoate esters featuring a new protocol for the carbonylative coupling of aryl bromides with boronic acids and a new strategy to favour carbonylative over non-carbonylative reactions. Two different synthetic pathways - (i) the alkoxycarbonylation of 2-bromo benzophenones and (ii) the carbonylative Suzuki-Miyaura coupling of 2-bromobenzoate esters - were evaluated. The latter approach
    我们已经开发出一种羰基化方法,用于合成不同取代的2-芳基苯甲酸酯,其特征是芳基化物与硼酸进行羰基化偶联的新方案,以及采用羰基化而非非羰基化反应的新策略。评估了两种不同的合成途径-(i)2-二苯甲酮的烷氧基羰基化和(ii)2-溴苯甲酸酯的羰基化Suzuki-Miyaura偶联-。后一种方法提供了更宽的基材耐受性,因此是首选途径。我们观察到2-取代的芳基化物是具有挑战性的羰基化化学底物,有利于非羰基化途径。但是,我们发现,缓慢添加硼酸可以改善羰基化的Suzuki-Miyaura偶联,
  • [EN] THIOXANTHONE DERIVATIVES, COMPOSITION COMPRISING THE SAME AND PATTERN FORMING METHOD COMPRISING SAID COMPOSITION<br/>[FR] DÉRIVÉS DE THIOXANTHONE, COMPOSITION LES COMPRENANT ET PROCÉDÉ DE FORMATION DE MOTIFS COMPRENANT LADITE COMPOSITION
    申请人:LINTFIELD LTD
    公开号:WO2020016389A1
    公开(公告)日:2020-01-23
    Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitated methods for producing photoresist structures.
    描述了潜在的光引发剂化合物,以及含有这种化合物的组合物,以及它们在用于生产光刻胶结构的光引发方法中的用途。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫